12:00 AM
 | 
Mar 26, 2012
 |  BC Week In Review  |  Company News  |  Other News

Unigene, Apotex musculoskeletal news

The U.S. Supreme Court denied a petition from generics company Apotex to review a decision from the U.S. Court of Appeals for the Federal Circuit (CAFC) in Apotex Inc. et al. v. Unigene Laboratories Inc. et al. that permanently enjoined Apotex from marketing its generic...

Read the full 203 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >